Breast Cancer Trial, Recruiting NCT04019678 Sponsor: Istituto Clinico Humanitas Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT04019678
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old
  • You have been diagnosed with invasive breast cancer (a type that has grown into surrounding breast tissue)
  • Your tumor is within a certain size range — classified as T1, T2, or T3 (confirm with trial site for exact measurements)
  • Your lymph nodes under the arm were found to be affected by cancer at the time of your first diagnosis, confirmed by physical exam, ultrasound, and tissue sampling
  • You have already received chemotherapy before surgery (called neoadjuvant chemotherapy)
  • After that chemotherapy, your underarm lymph nodes now appear cancer-free based on physical exam and ultrasound
  • There is no sign that the cancer has spread to other parts of your body
  • You have no previous history of invasive breast cancer

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have a specific type called inflammatory breast cancer
  • Your breast cancer is classified as "in situ" (meaning it has not spread beyond its original location)
  • You have breast cancer in both breasts at the same time
  • You have other health conditions that would prevent you from receiving follow-up cancer treatment after surgery
  • You have health or mental health conditions that would make it difficult to attend regular follow-up appointments
  • You have had another type of cancer in the past 3 years (except for certain skin cancers or early-stage cervical cancer — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituto Clinico Humanitas
Registry
ClinicalTrials.gov
Start date
21 June 2019
Est. completion
21 June 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Disease-free or death-free survival for any reason (DFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov